In lung adenocarcinoma, METTL7B was found to mediate the resistance to EGFR-tyrosine kinase inhibitors (EGFR-TKIs) via methylating GPX4, HMOX1, and SOD1 mRNA. This evidence concerns the gene EGFR and lung adenocarcinoma.